Find more ARC Seattle stories on our YouTube page
To view a copy of this license, visit About this article Cite this article Andrikopoulos, P., Aron-Wisnewsky, J., Chakaroun, R
To gain further insight into the different binding sites of Chc, we performed native mass spectrometry (native MS) experiments on Ent5.1 CBM, the strongest binder of the evaluated peptides (Supplementary Fig
The human studies that do exist are typically small (often fewer than 100 participants), short in duration (commonly eight to twelve weeks), and methodologically inconsistent, with significant heterogeneity in dosing, formulation, and outcome measures